Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21658067 | 0.87 | TSHR (0.51) | TSHRKDM4ELMNAHPGDMEN1 | |
| SCHEMBL19370866 | 0.82 | TSHR (0.75) | TSHRKDM4ELMNAHPGDMEN1 | |
| SCHEMBL17465487 | 0.81 | TSHR (0.54) | TSHRKDM4ELMNAHPGDMEN1 | |
| SCHEMBL27402755 | 0.81 | TSHR (0.50) | TSHRKDM4ELMNAHPGDMEN1 | |
| SCHEMBL16376361 | 0.81 | TSHR (0.50) | TSHRKDM4ELMNAHPGDMEN1 | |
| SCHEMBL16489191 | 0.81 | TSHR (0.73) | TSHRKDM4ELMNAHPGDMEN1 | |
| SCHEMBL23571289 | 0.81 | TSHR (0.67) | TSHRKDM4ELMNAHPGDMEN1 | |
| SCHEMBL14521249 | 0.80 | ALDH1A1 (0.47) | TSHRKDM4ELMNAHPGDMEN1 | |
| SCHEMBL21821634 | 0.80 | TSHR (0.84) | TSHRKDM4ELMNAHPGDMEN1 | |
| SCHEMBL21155013 | 0.79 | TSHR (0.70) | TSHRKDM4ELMNAHPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9114177-B2 | Block copolymer having phenylboronic acid group introduced therein, and use thereof | THE UNIVERSITY OF TOKYO (JP) | 2015-08-25 | — | — | US | disclosed |
| US-20150051347-A1 | BLOCK COPOLYMER HAVING PHENYLBORONIC ACID GROUP INTRODUCED THEREIN, AND USE THEREOF | THE UNIVERSITY OF TOKYO (JP) | 2015-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150051347-A1 | BLOCK COPOLYMER HAVING PHENYLBORONIC ACID GROUP INTRODUCED THEREIN, AND USE THEREOF | SLC1A5, BPGM, BDKRB1 | TSHR 1108/4885KDM4E 2428/4885LMNA 2273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.